Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Marsden

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Contemporary Clinical Trials|December 13, 2016
Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trialJohn Marsden, Garry Stillwell, Jennifer Hellier, et al.
Drug and Alcohol Dependence|December 6, 2025
Quality of life and treatment effectiveness direct and indirect effects on cocaine abstinence outcomes during cocaine use disorder treatmentCrystal L Smith, Sterling M McPherson, Nicole Rodin, et al.
Addiction (Abingdon, England)|April 20, 2018
The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United KingdomMatthew Hickman, Colin Steer, Kate Tilling, et al.
Health Technology Assessment (Winchester, England)|February 1, 2019
Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCTJohn Strang, Michael Kelleher, Soraya Mayet, et al.
Addiction (Abingdon, England)|February 5, 2017
Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in EnglandJohn Marsden, Garry Stillwell, Hayley Jones, et al.
Addiction (Abingdon, England)|June 29, 2010
Meta-analysis of drug-related deaths soon after release from prisonElizabeth L C Merrall, Azar Kariminia, Ingrid A Binswanger, et al.
Addiction (Abingdon, England)|September 6, 2022
The impact of the COVID-19 pandemic on addictive disorders-an updateJohn Marsden, Jamie Brown, Luke Clark, et al.
Addiction (Abingdon, England)|December 10, 2025
5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trialJohn Marsden, Michael Kelleher, Fiona Dunbar, et al.
Contemporary Clinical Trials Communications|September 2, 2025
ASSIST in Pitjantjatjara: Protocol for a randomised crossover validation study among Aboriginal and Torres Strait Islander AustraliansMatthew W R Stevens, Sue Bertossa, Dominic Barry, et al.
Addiction (Abingdon, England)|July 1, 2026
Craving and personal functioning as mediators of extended-release buprenorphine efficacy: A four-way decomposition analysis from a randomised trialJohn Marsden, Mike Kelleher, Fiona Cowden, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Contemporary Clinical Trials|December 13, 2016
Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trialJohn Marsden, Garry Stillwell, Jennifer Hellier, et al.
Drug and Alcohol Dependence|December 6, 2025
Quality of life and treatment effectiveness direct and indirect effects on cocaine abstinence outcomes during cocaine use disorder treatmentCrystal L Smith, Sterling M McPherson, Nicole Rodin, et al.
Addiction (Abingdon, England)|April 20, 2018
The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United KingdomMatthew Hickman, Colin Steer, Kate Tilling, et al.
Health Technology Assessment (Winchester, England)|February 1, 2019
Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCTJohn Strang, Michael Kelleher, Soraya Mayet, et al.
Addiction (Abingdon, England)|February 5, 2017
Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in EnglandJohn Marsden, Garry Stillwell, Hayley Jones, et al.
Addiction (Abingdon, England)|June 29, 2010
Meta-analysis of drug-related deaths soon after release from prisonElizabeth L C Merrall, Azar Kariminia, Ingrid A Binswanger, et al.
Addiction (Abingdon, England)|September 6, 2022
The impact of the COVID-19 pandemic on addictive disorders-an updateJohn Marsden, Jamie Brown, Luke Clark, et al.
Addiction (Abingdon, England)|December 10, 2025
5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trialJohn Marsden, Michael Kelleher, Fiona Dunbar, et al.
Contemporary Clinical Trials Communications|September 2, 2025
ASSIST in Pitjantjatjara: Protocol for a randomised crossover validation study among Aboriginal and Torres Strait Islander AustraliansMatthew W R Stevens, Sue Bertossa, Dominic Barry, et al.
Addiction (Abingdon, England)|July 1, 2026
Craving and personal functioning as mediators of extended-release buprenorphine efficacy: A four-way decomposition analysis from a randomised trialJohn Marsden, Mike Kelleher, Fiona Cowden, et al.
Pageof 15